, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the

% from the same period last year, and represented 37% of total revenues. This was due to the fact that the Company has focused on promotional activities were also organized jointly with leading shops and

strategy to focus on the large project since last year including with the quality of service and products which can meet efficiency the customer needs that made the Company got purchase order from large

. In order to maintain overall financial results, the Company has initiated strategies focused on improvements in operational efficiency and expense control, such as adapting to the ‘new normal’ of

customer orders and other chemicals decreased lower than the sale target. However, the company has focused on increasing the margin in sales which can be done above the average target of 18%. Manufacturing

chain as earlier explained. However, Branded export sales continued to grow outstandingly by c.25% as a result of the Company’s successful marketing strategy in each focused country as earlier explained

change of minimum payment from 5% increasing to 8%, and a higher number of customers paying in full compared to last year. Since the beginning of the fiscal year, the Company has focused on reactivating

. Therefore, we expect to see growth from coconut water again in 2018. In addition, in Q4/2017, there was some customer ending the distribution contract with some retailer, while there was some customer

) packages, which currently accounted for 20% of fixed broadband subscriber base, while a new platform of AIS PLAYBOX is being upgraded to enhance customer experience. As a result, ARPU slightly declined by

as a result of a drop of sales outside UK. ICUK’s sales from inside UK amount to THB 39 million, drop by THB 4 million or 10.2%, because ICUK focused on “Grocery Chain Store” which has large customer